New Working Group to Evaluate Clinical Utility of NGS-Based Testing to Inform Coverage After many years of steady development in DNA sequencing, the scientific community is reaching an exciting ...
The global rapid microbiology testing market is experiencing significant growth, driven by the need for faster infection ...
While next-generation sequencing (NGS) has become routine in academic settings, its use for patients with follicular lymphoma in the community is less consistent. There are disparities in the ...
NORTHFIELD, Ill.--(BUSINESS WIRE)--Precision medicine continues to gain momentum from the laboratory benchtop to the patient's bedside, with the CAP leading—as it has for over 10 years—in improving ...
Please provide your email address to receive an email when new articles are posted on . Real-world data show that only about 30% to 40% of patients with the most common cancers receive NGS testing.
Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...
A study presented at the American Society of Clinical Oncology Annual Meeting found practice- and provider-level racial and ethnic inequities in rates of next-generation sequencing (NGS) testing for ...
A low DNA binding consumables range minimizes interactions between nucleic acids and plastic surfaces, supporting more ...
Efficacy and safety of disitamab vedotin combined with toripalimab as neoadjuvant treatment for patients with locally advanced muscle-invasive bladder cancer: A mono-institutional retrospective study.
Dublin, Sept. 09, 2019 (GLOBE NEWSWIRE) -- The "Global NGS-Based Monitoring and Diagnostic Test Market: Focus on Application, Method, Type, End User, Country Data (17 Countries), and Competitive ...
China possesses the capacity to monitor the Nipah virus through next-generation sequencing (NGS), said Chinese infectious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results